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Shiga toxin-producing Escherichia coli (STEC) is an important foodborne pathogen
capable of causing severe disease in humans. Rapid and accurate identification
and characterization techniques are essential during outbreak investigations. Current
methods for characterization of STEC are expensive and time-consuming. With the
advent of rapid and cheap whole genome sequencing (WGS) benchtop sequencers, the
potential exists to replace traditional workflows with WGS. The aim of this study was to
validate tools to do reference identification and characterization from WGS for STEC in a
single workflow within an easy to use commercially available software platform. Publically
available serotype, virulence, and antimicrobial resistance databases were downloaded
from the Center for Genomic Epidemiology (CGE) (www.genomicepidemiology.org) and
integrated into a genotyping plug-in with in silico PCR tools to confirm some of the
virulence genes detected from WGS data. Additionally, down sampling experiments
on the WGS sequence data were performed to determine a threshold for sequence
coverage needed to accurately predict serotype and virulence genes using the
established workflow. The serotype database was tested on a total of 228 genomes and
correctly predicted from WGS for 96.1% of O serogroups and 96.5% of H serogroups
identified by conventional testing techniques. A total of 59 genomes were evaluated
to determine the threshold of coverage to detect the different WGS targets, 40 were
evaluated for serotype and virulence gene detection and 19 for the stx gene subtypes.
For serotype, 95% of the O and 100% of the H serogroups were detected at> 40x and≥
30x coverage, respectively. For virulence targets and stx gene subtypes, nearly all genes
were detected at > 40x, though some targets were 100% detectable from genomes with
coverage ≥20x. The resistance detection tool was 97% concordant with phenotypic
testing results. With isolates sequenced to > 40x coverage, the different databases
accurately predicted serotype, virulence, and resistance from WGS data, providing a
fast and cheaper alternative to conventional typing techniques.
Keywords: Escherichia coli, whole genome sequence, STEC, next generation sequencing, stx subtyping,
Escherichia coli serotypes
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INTRODUCTION
Foodborne bacteria pose a major threat to public health. To
prevent widespread infections due to these bacteria as well as
detect outbreaks, rapid and accurate identification and subtyping
of these bacteria is key. Shiga toxin-producing Escherichia coli
(STEC) is an important foodborne pathogen estimated to cause
over 265,100 illnesses each year in the United States (Scallan
et al., 2011). STECmay present as a mild gastroenteritis, diarrhea,
grossly bloody diarrhea and hemolytic uremic syndrome (HUS),
and infection may be fatal. In the United States an estimated
96,500 O157 STEC and 168,690 non-O157 STEC infections occur
each year and result in over 3600 hospitalizations and 30 deaths
annually (Scallan et al., 2011).
STEC is a nationally reportable disease in the U.S. and
clinical laboratory requirements for forwarding the STEC
positive isolate or specimen to the public health laboratory
vary by state. Once a STEC positive isolate or specimen
arrives at the local or state public health laboratories it
undergoes further characterization. These isolates are routinely
subtyped using pulsed-field gel electrophoresis (PFGE) and
submitted to the national surveillance network for foodborne
bacteria, PulseNet, as well as characterized using conventional
techniques for phenotype, serotype, and virulence. Workflows
at public health laboratories for characterization for STEC can
vary, current methods for characterization of STEC in the
Enteric Diseases Laboratory Branch at the Centers for Disease
Control and Prevention include panels of 22–49 phenotypic
tests for identification, agglutination assays with 270 pooled
and individual O- and H-specific antisera for serotyping
(determination of 188 O and 53 H antigens), panels of five to
10 PCR assays for virulence profiling and broth microdilution
assays for antimicrobial susceptibility testing. These methods
require complex workflows, expensive reagents, labor-intensive
quality control procedures, specialized training, and typically
take 1–3 weeks to complete. Therefore a need exists to simplify
workflows and reduce costs and time associated with subtyping
and characterization of STEC, possibly through whole genome
sequencing.
Whole genome sequencing (WGS) using benchtop
instruments makes WGS possible in a public health lab
setting. These machines are relatively easy to operate; the cost
per isolate is low; and turnaround time for generating WGS
data is within days rather than the 1–3 weeks required for
current, conventional methods. Since the serotype, virulence
and antimicrobial resistance profile may be predicted from
the genome sequence, WGS may replace almost all reference
characterization of STEC in the public health laboratory.
Additionally, the sequence data also provide a level of strain
discrimination and precision that is better than any subtyping
method hitherto used for outbreak detection and investigation.
Thus, almost all characterization of STEC in the public health
laboratory can be replaced by WGS using one single efficient
workflow. However, converting the WGS data into interpreted
output that is useful for public health professionals is a real
challenge.
To address this challenge, The Center for Genomic
Epidemiology (CGE) (www.genomicepidemiology.org) has
developed a suite of web-based tools for in silico analysis of
bacterial whole genome sequence (Cosentino et al., 2013;
Joensen et al., 2014). These tools include a serotype detection
procedure (SerotypeFinder) and resistance and virulence
prediction tool (ResFinder and VirulenceFinder) for analysis
of E. coli and other bacterial WGS data (Zankari et al., 2013;
Kleinheinz et al., 2014; Joensen et al., 2015). To characterize an
isolate, WGS is uploaded to the website, and depending on the
analysis requested, a report of the isolate’s serotype, virulence,
and resistance gene content is returned within several minutes
to hours. Since many WGS analysis tools will accept data of
any quality, it is important to understand the data quality
requirements for the information being sought to interpret
negative results correctly.
Although the CGE tools are useful for analysis in a setting
where the isolate throughput is low and data analysis is
centralized, for WGS analysis tools to be effective in a public
health laboratory setting that processes tens to hundreds of
WGS isolate sets per week, all the tools need to be merged
into a single platform that performs WGS quality assessment
and can also be used with a database that includes sufficient
patient and sample information about the isolates to be able
to interpret them in the proper epidemiological context, e.g.,
the outbreak setting. Moreover, the platform needs to be simple
and user-friendly so that it may be used by public health
professionals with limited bioinformatics skills. While numerous
commercial and public domain software are available to analyze
WGS data, very few combine databasing, WGS and other
analytical capabilities, which are highly desirable in national and
international laboratory surveillance networks. One exception
is BioNumerics v7.5 R© (Applied Maths, Austin, TX), which is a
commercial, customizable WGS quality assessment, analysis, and
database software package thatmay be used for all these purposes.
Thus the serotype, virulence, and resistance gene detection tools
from CGE and in silico PCR tools to confirm results from
virulence prediction tools can be integrated into a single push
button tool in BioNumerics v7.5 R©, the genotyping plug-in. This
plug-in can be used in the same database that contains the
sequence data for subtyping for surveillance purposes and only
requires a de novo assembled genome. Therefore, within the one
software platform, reference characterization and WGS analysis
for outbreak detection can be performed rapidly and requires
little bioinformatics training for the user.
In this study, we performed validation of a genotyping plug-
in within BioNumerics for identification of O and H genes using
a diversity set of nearly 200 genomes. We further demonstrated
the utility of the detection tools within the genotyping plug-in on
isolates that were sequenced in-house and tested by traditional
methods for serotype, virulence gene content, and antimicrobial
susceptibility. In addition, we down-sampled the sequence reads
of the later set to determine the minimum genome coverage
needed for the program to detect the intended target genes and
present in silico PCR tools to confirm selected results of the
virulence detection tool.
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MATERIALS AND METHODS
Whole Genome Sequencing and Analysis
Validation of the genotyping plug-in within BioNumerics
version 7.5 was performed using whole genome sequences
of nearly 300 in-house sequenced and publically available
STEC genomes for which conventional serotyping results were
also available. The sequence data were generated on PacBio,
Roche 454, and Illumina sequencing platforms (Table S1).
An additional 17 genomes of Shigella and corresponding
antimicrobial susceptibility testing data were included to evaluate
the resistance finder tool. Moreover, a set of 106 isolates with
traditional serotype and virulence PCR results performed in
house were sequenced on the IlluminaMiSeq or HiSeq sequencer
platforms and selected for the down sampling experiment (Table
S1). For in-house sequenced isolates, DNA was extracted using
the Qiagen Blood and Tissue kit, libraries were prepared using
NexteraXT (MiSeq) or NEB Next (HiSeq), and sequenced on
the MiSeq or HiSeq using 2 × 250 bp chemistry. Sequence
quality was evaluated on a per genome basis using BioNumerics
version 7.5 R©. All genomes passed the basic quality metrics for
raw sequence data from Illumina sequencers of average Q-
score >30 in both reads and at least 40X average coverage with
expected genome size for E. coli of 5 Mb. Read files of in house
generated sequence data were uploaded to NCBI SRA using
BioNumerics v.7.5 NCBI uploader (see Table S1). Genomes were
processed through the BioNumerics Calculation Engine for de
novo assemblies using the wgMLST client plug-in. The assembly
was done using SPAdes version 3.5.0 integrated into the wgMLST
plug-in and basic assembly metrics were calculated and used for
quality assessment.
Analysis Using Genotyping Plug-in
Assembled sequence data was analyzed using the genotyping
plug-in. The genotyping plug-in contains databases for
serotype, virulence and resistance prediction (consisting
of annotated allelic variants for genes encoding serotype,
virulence factors and antimicrobial resistance), and for
plasmid and prophage detection obtained from the Center
for Genomic Epidemiology (DTU, Lyngby, Denmark)
(https://cge.cbs.dtu.dk/services/data.php). The genotyping
plug-in also contains an in silico PCR tool for the detection of
Shiga toxin gene subtypes and virulence genes using previously
published primers (Paton and Paton, 1998; Scheutz et al., 2012).
The various “finder” tools use a blast-based approach to detect
the genes of interest in the de novo assembled genome, and
subsequently identifies them against the appropriate reference
database. Detection parameters were set to 90% sequence
identity and 60% sequence coverage. As a quality metric and
a guard against blindly extrapolating the serotype, virulence
or resistance prediction, for each similarity-based association,
a discrimination score is calculated, indicating how good the
closest known allele in the respective database fits the sample
data with respect to the runner-up allele. The in silico PCR tools,
mimicking the wet lab PCR process, excise a particular part of
the genome, defined by forward and reverse primer pairs. In
detecting a primer, at most 1 mismatch was allowed.
Downsampling Analysis
A set of 59 genomes were downsampled. A set of 40 genomes
were used to validate the serotype and virulence gene finder,
and the remaining set of 19 were used to validate the stx
subtyper. The genomes were downsampled to 40x, 30x, 20x,
and 10x coverage using the Computational Genomics Pipeline
(CG-Pipeline; https://github.com/lskatz/CG-Pipeline; Katz et al.,
2011). Downsampled genomes were assembled and analyzed
using the genotyping plug-in BioNumerics v.7.5 with the settings
outlined above to determine limit of detection for WGS-based
identification tools.
Conventional Testing Procedures
Conventional testing of isolates was completed in the Escherichia
Shigella reference laboratory at the Centers for Disease Control
and Prevention, USA. Serotyping was performed with O- and H-
specific antisera from the Statens Serum Institut (Copenhagen,
Denmark) by standard methods in a microtiter format (Ewing,
1986). For the virulence genes real-time or conventional PCR
for the presence of Shiga toxin 1 and 2 (stx1, stx2), stx
subtyping (stx1a, stx1c, stx1d, stx2a, stx2c, stx2d, stx2e, stx2f,
and stx2g), intimin (eae) and hemolysin (ehxA) genes was
performed (Paton and Paton, 1998; Scheutz et al., 2012). Broth
microdilution assays to determine antimicrobial susceptibility
was done by the National Antimicrobial Resistance Monitoring
(NARMS) laboratory using previously published techniques
(CDC, 2013). Resistance data were interpreted using Clinical
Laboratory Standards Institute criteria (Clinical Laboratory
Standards Institute, 2012).
RESULTS
Validation of the Serotype Detection Tool in
BioNumerics
The serotype detection tool within BioNumerics was validated
on a total of 188 isolates for which WGS data and conventional
serotype information was available. These publically available
genomes were sequenced by either PacBio, Illumina, or 454
technology (see Table S1). The genomes represent 30 O
serogroups and 26 H serogroups for a total of 76 serotypes
(Table 1). Several representatives of the top 20 serotypes as well as
a representation of a diverse collection of serotypes were selected
for this set of genomes.
A total of 29 O and 25 H serogroups were identified from
the WGS data of the 30 O and 26 H serogroups detected
by conventional methods, one O118 serogroup isolate was not
detected by WGS data, and an H47 isolate was typed as an H7
by WGS. Comparisons to the traditional O serogroup results
with the predictions from the WGS data showed that 96.3%
(181/188) of the O serogroups were accurately predicted from
the WGS data. For the H serogroup, 95.9% (164/171) of the H
antigens were accurately predicted from theWGS data, H antigen
detection for non-motile isolates was not counted since such
isolates are non-typable by the phenotypic methods (Table 1).
There were only 4 isolates that had a different O serogroup
predicted and 6 isolates that had a different H serogroup
predicted compared to traditional typing results (see Table S1).
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TABLE 1 | Validation of serotype detection tool within the genotyping
plug-in on a set of 188 isolates.
Antigen Number of strains
phenotypically determined or
reported in the literature with
antigen
Number of strains with
antigen determined by WGS
in agreement with
phenotypically determined
antigen
O1 3 2b
O2 2 2
O6 10 10
O7 4 4
O8 3 3
O9 3 3
O15 2 2
O16 7 7
O18 3 3
O25 3 3
O26 12 11a
O45 3 3
O55 20 20
O78 2 2
O83 2 2
O91 6 5a
O103 4 4
O104 4 4
O111 23 23
O118 1 0b
O119 1 1
O121 2 2
O127 1 1
O128 16 15a
O145 8 7b
O146 2 2
O149 2 1a
O157 36 35
O165 1 1
O174 3 3
H1 8 8
H2 18 18
H4 8 8
H6 13 13
H7 40 40
H8 5 4b
H9 2 2
H11 13 11a
H12 4 3a
H14 1 1
H16 2 2
H17 1 1
H19 6 6
H20 2 2
H21 16 14a
H25 4 4
(Continued)
TABLE 1 | Continued
Antigen Number of strains
phenotypically determined or
reported in the literature with
antigen
Number of strains with
antigen determined by WGS
in agreement with
phenotypically determined
antigen
H28 4 4
H31 1 1
H34 1 1
H37 1 1
H39 1 1
H43 4 4
H45 5 5
H47 1 0a
H48 7 7
H49 3 3
Number of isolates given for positive by conventional and WGS serotype tests (isolate
details listed in Table S1). 17 isolates were non-motile by traditional testing and not
counted in the H WGS test results.
aDescrepant conventional and WGS serotyping results are noted by isolate in Table S1.
bAntigen not predicted from WGS data.
These were not sequenced by us but were downloaded from
NCBI and it is possible that the data on NCBImay contain errors.
However, since we do not have access to these isolates we cannot
confirm the WGS results and phenotype. Overall, the serotyper
tool predicted the serotype correctly in 94.2% (161/171) of the
tested genomes.
Robustness of Serotype and Virulence
Gene Prediction in WGS Datasets
To determine the sensitivity of the serotype and virulence gene
predictions by WGS, a set of 40 isolates was selected that had
all been sequenced by Illumina MiSeq or HiSeq and serotyped
and virulence gene characterized using PCR methods. These
genomes ranged in coverage from 40x to 267x coverage. Using
the serotype detection tool in the genotyping plug-in, all but
one of the O serogroups were predicted (95%) (38/40 isolates),
both isolates belonging to the O153 serogroup were not predicted
(Table 2). For those isolates where no O serogroup was predicted,
the genomes ranged from 119x to 153x coverage, suggesting
that sequence coverage was not a factor in being able to predict
this particular serogroup. All of the H serotypes were predicted
correctly when considering motile isolates, i.e. isolates that could
be phenotypically verified by agglutination. The sequencing
reads per isolate were then randomly down sampled to 40, 30,
20, and 10 times coverage and then analyzed in BioNumerics.
These genomes were assembled de novo and the serotype and
virulence genes predicted. In the down-sampled datasets, at 40x
coverage 77.5% of O and 100% of H serogroups were correctly
identified. For the remaining 30x, 20x, and 10x coverage levels,
O serogroups were predicted correctly in 77.5, 52.5, and 17.5% of
isolates and H serogroups were predicted in 100, 95, and 70% of
isolates, respectively. The best prediction of O and H serogroup
was from genomes at greater than 40x coverage.
For the original sequence and 40x, 30x, and 20x down sampled
genomes, there was 100% concordance between the virulence
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TABLE 2 | Limit of detection for O and H antigens in a downsampled WGS data set from 40 strains.
Antigenb Number of strains with phenotypically
determined antigen
Number of strains by WGS having the phenotypically determined antigen at different
sequence coverage levels
Original sequence
coveragea
40x coverage 30x coverage 20x coverage 10x coverage
O5 2 2 2 2 2 1
O26 2 2 2 2 1 0
O45 2 2 2 2 1 1
O69 2 2 2 2 1 0
O71 2 2 2 2 2 2
O76 2 2 2 2 2 1
O80 2 2 2 2 1 0
O91 2 2 2 2 0 0
O103 2 2 2 2 2 0
O104 2 2 2 2 0 0
O111 2 2 2 2 2 0
O113 2 2 2 2 1 0
O118 2 2 1 2 1 0
O121 2 2 2 2 2 2
O145 2 2 0 0 0 0
O146 2 2 1 1 1 0
O153 2 0 0 0 0 0
O157 2 2 2 2 2 0
O165 2 2 0 0 0 0
O174 2 2 2 0 0 0
H2 7 7 7 7 7 6
H4 3 3 3 3 3 2
H7 3 3 3 3 3 2
H8 2 2 2 2 2 2
H11 5 5 5 5 5 4
H14 1 1 1 1 1 1
H16 2 2 2 2 2 2
H19 4 4 4 4 4 2
H21 3 3 3 3 3 2
H25 1 2 2 2 2 1
H28 3 3 3 3 2 2
Strain identifiers listed in Table S1.
aOriginal coverage ranged from 40 to 267x.
bSix H serogroups were called from the WGS data that were typed as non-motile by conventional methods and not included here.
detection tool and in silico PCR and conventional real-time PCR
assay for Shiga toxin 1 and 2 (stx1, stx2), intimin (eae), and
hemolysin (ehxA) genes when a call was made (see Table 3).
At 10x coverage, few virulence genes were identified from the
WGS. The virulence detection databases did not identify stx2
in a STEC O76:H19 isolate which was detected by in silico
PCR. Additionally, the in silico PCR did not identify stx2 in
two isolates that were identified as stx2 positive by the virulence
detection tool databases. By using both the virulence detection
databases and in silico PCR, all stx2 positive isolates identified by
conventional typing methods were also identified from the WGS
at 20x coverage or higher. For the other virulence gene targets,
stx1 was detected in all 21 of the isolates positive by conventional
testing at ≥ 20x coverage, eae in all 26 at ≥ 30 coverage, and
ehxA gene detection fromWGS data was 100% concordant in the
assemblies from the original sequence read set.
Prediction of stx Gene Subtype Using
Virulence Gene Database and In silico PCR
A total of 19 isolates were examined that had complete
conventional stx gene subtype results and WGS results. These
isolates represented the a, c, and d subtypes of stx1 and the a, b, c,
d, e, f, and g subtypes of stx2. All the stx subtypes except stx2c were
detected using the in silico PCR tool or the virulence detection
database at original coverage levels and down to 10x coverage
(see Table 4). For stx2c, only one of the two isolates identified
as positive by conventional laboratory testing was detected as
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TABLE 3 | Limit of detection of virulence genes in a down sampled WGS data set from 40 STEC and one hybrid STEC/EAEC O104:H4 by both a blast and
in silico PCR approach.
Trait Number of
strains with trait
by real-time PCR
Number strains determined from WGS data with indicated trait at different sequence coverage levels
Original sequence
coveragea
40x coverage 30x coverage 20x coverage 10x coverage
Blast In silico PCR Blast In silico PCR Blast In silico PCR Blast In silico PCR Blast In silico PCR
stx1 27 27 27 27 27 27 27 27 27 25 26
stx2 21 20b 19c 20 19 20 20 20 20 20 18
eae 26 26 26 26 24 26 26 24 20 8 9
ehxA 29 29 29 26 26 25 25 17 20 8 11
Strain identifiers listed in Table S1.
aOriginal coverage was 40x to 267x.
bFor the original sequence files, stx2 was missed in an E. coli O76:H19 using the genotyping plug-in that was detected by in silico PCR.
cThe in silico PCR did not detect stx2 in 2 isolates though it was detected by the genotyping plug-in.
TABLE 4 | Limit of detection of stx gene subtype in a downsampled WGS data set for 19 strains by both a blast and in silico PCR approach.
Trait Number of
strains with trait
by real-time PCR
Number strains determined from WGS data with indicated trait at different sequence coverage levels
Original sequence
coverage
40x coverage 30x coverage 20x coverage 10x coverage
Blast In silico Blast In silico Blast In silico Blast In silico Blast In silico
PCR PCR PCR PCR PCR
stx1a 2 3 2 2 2 2 2 2 2 2 2
stx1c 1 1 1 1 1 1 1 1 1 1 0
stx1d 2 2 2 2 2 2 2 2 2 2 1
stx2a 2 2 2 2 2 2 2 1 2 2 1
stx2b 3 2 3 2 3 2 3 3 3 3 2
stx2c 2 0 1 0 1 0 1 0 0 0 0
stx2d 3 3 3 3 3 3 3 3 2 3 2
stx2e 1 1 1 1 1 1 1 1 1 1 1
stx2f 7 7 7 7 7 7 7 7 7 7 6
stx2g 1 1 1 1 1 1 1 1 1 1 1
see Table S1 for isolate identification.
positive from the WGS using in silico PCR. One isolate was
positive for stx1a using blast against the virulence gene database
but was negative by both conventional testing using PCR and the
in silico approach. Looking further into this discrepancy, using
the blast based approach the gene was only a 82.3% length match
compared to the reference allele and may indicate the gene was
truncated so that the reverse primer used in the traditional or in
silico PCR assay would not hybridize. Overall, stx gene subtype
was correctly predicted in 89.5% of isolates at ≥ 10x coverage.
Validation of the Resistance Finder Tool in
BioNumerics
The resistance finder tool in BioNumerics was evaluated
against a set of 46 isolates where WGS and traditional
antimicrobial susceptibility results were available. Several
of the isolates tested, a total of 28 out of the 46, were pan-
susceptible by both antimicrobial susceptibility testing and
did not contain resistance genes by WGS (see Table 5). Of
the remaining STEC and Shigella that were found to be
resistant by traditional antimicrobial susceptibility testing, the
concordance for detecting genetic antimicrobial resistance
determinants for ampicillin, azithromycin, chloramphenicol,
sulfisoxazole, streptomycin, and trimethoprim/sulfamethoxazole
was 100%. One isolate was found to contain tetracycline
resistance genes that did not test as resistant by conventional
testing. No genetic resistance determinants were detected
for isolates resistant to nalidixic acid and ciprofloxacin
using the ResFinder database. Through further genetic
analysis, it was determined that these isolates were resistant
via chromosomal mutations in the gyrA gene alone or in
combination with mutations in the parC gene. These results are
not unexpected as gene detection schemes can identify non-
functional genes and do not detect mutational events. Taking
these issues into account, there was 99.7% concordance between
phenotypic susceptibility and antimicrobial resistance detection
by WGS.
Frontiers in Microbiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 766
Lindsey et al. Escherichia WGS for Reference Characterization
TABLE 5 | Comparison of phenotypic antimicrobial susceptibility testing
results with resistance determinants identified from WGS data in 46
strains.
Antimicrobial Phenotypic
laboratory testing
Resistance
determinant
detection from
WGS data
Ampicillin 12 12
Azithromycin 13 13
Chloramphenicol 1 1
Streptomycin 18 18
Sulfisoxazole 18 18
Nalidixic acid 9 0
Ciprofloxacin 6 0
Trimethoprim/Sulfamethoxazole 18 18
Tetracycline 17 18
No Resistance detected 28 28
Values indicate the number of strains identified with resistance to the indicated
antimicrobial.
DISCUSSION
In this study, we demonstrated the utility and accuracy of a
single software platform for combining workflows for quality
assessment and reference characterization of STEC throughWGS
data. A single software program that can be used by non-
bioinformaticians is a requirement for public health professionals
to be able to infer phenotypic results from WGS data. Using
publically available databases and in silico PCR tools developed as
part of this study, we identified the same information (serotype,
virulence genes, and resistance determinants) from theWGS data
for 94.7% E. coli and Shigella isolates as was identified previously
by conventional methods. Additionally, the limit of detection
for these determinants was established through down sampling
experiments allowing for better interpretation of negative results
and understanding of sequence data quality needed for reference
characterization fromWGS.
Although, other recent studies have already shown the
utility of reference characterization directly from sequence data
generated from benchtop sequencers (Joensen et al., 2014,
2015; DebRoy et al., 2016), we present the combined quality
assessment, serotyping, virulence profile, and resistance profile in
one simple, high-throughput, and user-friendly analytical WGS
workflow. These previous studies extensively validated their
findings against those obtained by conventional methods, yet
limited testing was done to identify the limit of detection for
these tools and how best to interpret a negative result. Often in
these studies, sequences were selected because they were of high
quality and had high coverage, typically over 50x. While high
sequence quality and coverage may be possible during routine
testing periods, it is often difficult to achieve during outbreak
response or when trying to reduce testing costs. When there is
a need to increase isolate multiplexing per sequencing run to
increase throughput and reduce costs, sequence coverage per
isolate decreases. For this reason we attempted to determine the
limits for coverage to help determine the maximum number of
isolates that could be sequenced at the same time. In our study,
sequence coverage of ≥30 was enough to predict 100% of the
H serogroups, for the O serogroups 93% of the serogroups were
correctly predicted at a sequence coverage> 40x. One O antigen,
O153 (2 isolates), was not detected in genomes sequenced to over
100x coverage. Since other groups have shown that O153 genes
wzx and wzy are 100% identical to the O178 genes, even though
surprisingly these two serogroups are not cross-reactive using
phenotypic testing, the current similarity-based WGS detection
methods may not be able to distinguish these closely-related
serogroups (Joensen et al., 2014, 2015; DebRoy et al., 2016).
Virulence gene detection performed more robustly than O
and H antigen gene detection. The majority of virulence genes
were detected at ≥20x coverage in the WGS data using the
genotyping plug-in. Since both serotype and virulence gene
information is needed for STEC surveillance, to be able to
consistently identify serotype from WGS in all isolates >40x
coverage is recommended. Preliminary data (not presented)
indicates that this coverage will also suffice for subtyping for
outbreak investigations using whole genomemultilocus sequence
typing analysis.
To improve confidence in negative WGS results, additional
in-silico PCR tools were developed to double check negative
results from whole genome sequence data. This provided further
confidence in virulence typing results. By using both WGS
typing tools, all virulence genes were detected, by relying on
either tool alone, blast algorithm or in silico PCR, important
virulence genes would have been missed. Being able to accurately
identify virulence genes and stx gene subtypes is important
because certain virulence gene combinations are associated
with higher risks for adverse events, e.g., HUS (Scheutz
et al., 2012). Other groups have also shown the robustness of
determining stx gene subtypes from WGS from both O157 and
non-O157 serogroups (Ashton et al., 2015; Chattaway et al.,
2016).
For identification of resistance determinants, the ResFinder
database produced highly concordant results with traditional
phenotypic testing. Isolates possessing quinolone resistance
mechanisms that were not identified by the ResFinder database,
underscore the limitations of a gene-based detection approach.
Supplementary in silico PCRs using conventional primer
sets (Conrad et al., 1996; Bhattacharya et al., 2013) and
subsequent sequence analysis or reference-mapping tools can
be used in conjunction with the resistance finder tool, in
order to detect mutational events conferring antimicrobial
resistance. A recent study examining multi-drug resistant E.
coli in the United States accurately predicted drug resistance
with high specificity and sensitivity using a WGS approach
that employed gene-based detection in conjunction with
mutational analysis of the quinolone resistance-determining
regions of the chromosome (Tyson et al., 2015). The present
study confirms this high concordance between genetic
and phenotypic testing for antimicrobial resistance, and
also reveals the ability of this WGS-based approach to
distinguish resistant and susceptible isolates for most drug
classes.
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From this study, it has been shown that quality assessment,
serotyping, virulence and resistance profiling can be performed
in one simple workflow. Additionally, the information that
is extracted from WGS has more details than provided
by conventional methods, e.g., by conventional methods we
routinely detect only 5 virulence targets and 9 antimicrobial
susceptibilities whereas over 100 virulence and resistance
determinant genes are detected by WGS. Extracting this
information from the whole genome sequence rather than using
traditional identification techniques is highly cost-efficient: it
is possible to save up to 180 US dollars on reagents alone
per characterized isolate (assuming $123 for WGS and $304
for traditional typing workflow per isolate), which makes
WGS both more rapid and less expensive for typing STEC.
Additionally other groups (Joensen et al., 2014) have shown
that the turnaround time for WGS is faster compared to
conventional reference identification and subtyping workflows.
We have also seen that the turnaround time from receipt of
isolate in lab to WGS result can be 3–4 days while conventional
methods take 1–3 weeks. While there is a high initial overhead
cost of the sequencing instrument, WGS has the potential to
streamline laboratory work into a unified workflow, reducing
the need for multiple specialized personnel and instruments
for various genotypic and phenotypic testing. Furthermore, by
understanding the limit of detection by WGS for these different
targets, there is more confidence that a negative result is an
accurate prediction, though further work needs to be done to fine
tune the serotype and resistance finder databases.
FUTURE WORK
For future work on the genotyping plug-in within BioNumerics,
we plan to integrate more gene identification techniques
from the whole genome sequence, such as reference mapping,
to improve the ability to detect serogroups and resistance
determinants. Lastly, although this validation was done for
reference characterization and a minimum coverage requirement
was identified, similar tests need to be performed in terms of
WGS analysis for outbreak detection. Currently we are validating
a whole genome multilocus sequence typing (wgMLST) database
for STEC.
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